Cart
0
Get 20% Free Customization In This Report
Buy this report from - $4176

Cardiac Surgical Devices Market by Product Type (Beating Heart Surgery Systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices, and Perfusion Disposable), by Application (Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure), and by Age Group (New-born, Infant, Children, and Adults) - Global Opportunity Analysis and Industry Forecast, 2017-2023

LI_172177
Pages: 180
Apr 2017 | 1584 Views
face gplus_n
Author's : Shubhangi Bawkar and Abha Thakur
Tables: 62
Charts: 50
twit_n pr_n

Cardiac Surgical Devices Market Overview:

Global Cardiac Surgical Devices Market accounted for $1,700 million in 2016, and is estimated to reach $2,124 million by 2023, growing at a CAGR of 3.2% during the analysis period (2017-2023). There is a high prevalence of cardiac diseases worldwide, hence an increase in the number of cardiac surgeries. Products such as beating heart surgery systems, cardiopulmonary bypass equipment, cardiac ablation devices, and perfusion disposable are used for cardiac surgery.

The key factors that drive the growth of cardiac surgical devices market include rise in incidence & prevalence of cardiovascular diseases. In addition, the rise in healthcare expenditure and healthcare insurance are expected to fuel the market growth during the analysis period. However, shortage of experienced healthcare professionals and lack of awareness among the population restrict the growth.

Cardiac Surgical Devices Market Segmentation

Cardiac Surgical Devices Market Segmentation

Segment Review

Based on product type, the global cardiac surgical devices market is categorized into beating heart surgery systems, cardiopulmonary bypass equipment, cardiac ablation devices, and perfusion disposable. Perfusion disposables held the highest market share and is expected to grow with the highest growth rate during the forecast period. The growth of the perfusion disposable market is fueled by the growth in use of perfusion disposables during cardiac surgical procedure for transferring the blood to different parts of the body. On the basis of application cardiac arrhythmia held the highest market share owing to the high prevalence of cardiac arrhythmia.

Top Investment Pocket

Cardiac Surgical Devices Market - Top investment pocket

Geographic Review:

Geographically, the global cardiac surgical devices market is segmented into North America, Europe, Asia-Pacific, and LAMEA. North America held the largest share of the market in 2016, followed by Europe. On the other hand, Asia is anticipated to be the fastest-growing regional segment during the analysis period. The key factors that drive the growth of this market include increase in pool of patient population, rise in prevalence of cardiovascular diseases, and rise in government investments for development of better healthcare facilities and R&D. Asia-Pacific is expected to emerge as the area with maximum growth potential due to the focus of key players in the emerging economies and improving healthcare infrastructure.

India Cardiac Surgical Devices Market ($Million), 2016-2023

India Cardiac Surgical Devices Market, 2016-2023

Growth in Incidence of Cardiac Diseases

Majority of the deaths, worldwide, are due to cardiac diseases; accounting for 17.3 million deaths per year, and projected to grow more than 23.6 million by 2030. American Heart Association (AHA) estimated that approximately 31% of total deaths globally in 2013, were because of cardiac diseases. Around 80% of those cardiac deaths were from low and middle income countries. These factors majorly drive the growth of the cardiac surgery devices market.

In addition, rise in incidences of diabetes, atherosclerosis, strokes, hypertension, and other chronic disorders that arise due to change in lifestyle habits (such as unhealthy dietary habits, lack of physical activity, and smoking) are also expected to boost the growth of the market, as the aforementioned factors lead to disorders of the circulatory system.

Large Pool of Geriatric Population

The global geriatric population has increased significantly and is vulnerable to various cardiac disorders, such as stroke, cardiac arrest, cardiomyopathy, and arrhythmias. For instance, according to the estimates of American Heart Association (2015), approximately 43.7 million suffered from cardiovascular disorders and above the age of 60 years in the U.S. alone. In addition, 69.1% of men and 97.9% of women, aged between 60 and 79 years, had cardiac disorders in 2015, in the U.S. Similarly, about two-thirds of deaths are from cardiac diseases in the people aged 75 and above. Emerging countries have high number of elderly population throughout the world. For instance, according to the estimates of Central Intelligence Agency (CIA) in 2016, approximately 27.3% of population were above 65 years. Therefore, the escalation in rate of the geriatric population is expected to raise the demand for surgical procedures, thereby driving the cardiac surgery devices market.

Major companies operating in this market adopt product launch as their key development strategy. Companies profiled in this market include, Edwards Life Science Corporation, Medtronic Inc., Getinge Group, Atrion Corporation, Abbott Laboratories, Sorin S.P.A., Terumo Medical Corporation, Boston Scientific Corporation, Cook Medical, and Angiodynamics, Inc.

Other players (the profiles of these players are not covered in the report) in the value chain include C. R. Bard, Inc., Trinity Biotech, Abiomed, Inc., Cardinal Health, CyberHeart Incorporated, MedWaves Incorporated, and Transmedics, Inc.

Key Market Benefits:

  • The study provides an in-depth analysis of the cardiac surgical devices market with current trends and future estimations to elucidate the imminent investment pockets
  • The report provides a quantitative analysis from 2016 to 2023 to enable the stakeholders capitalize on prevailing market opportunities
  • Extensive analysis by product and application helps understand various trends and prevailing opportunities in the respective market
  • Comprehensive analysis of all geographical regions is provided, which determines the main opportunities in these geographies
  • Key market players are profiled and their strategies are analyzed thoroughly, which predict the competitive outlook of the market

Cardiac Surgical Devices Market Key Segment:

By Product Type

  • Beating Heart Surgery Systems
  • Cardiopulmonary Bypass Equipment
  • Cardiac Ablation Devices
  • Perfusion Disposables

By Application

  • Congenital Heart Defects
  • Cardiac Arrhythmia
  • Coronary Heart Disease
  • Congestive Heart Failure
  • Other Applications

By Age Group

  • New-born (0-30 days)
  • Infant (31 days-1 year)
  • Children (1-18 years)
  • Adult (18+ years)

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Others
  • Asia-Pacific
    • Japan
    • China
    • India
    • Others
  • LAMEA
    • Latin America
    • Middle East
    • Africa
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENT
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTER’S FIVE FORCES ANALYSIS

3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Competitive rivalry

3.4. MARKET SHARE ANALYSIS, 2016
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Growing incidence of cardiac diseases
3.5.1.2. Large pool of geriatric population
3.5.1.3. Technological advancements

3.5.2. Restraints

3.5.2.1. High cost of cardiac surgery procedures

3.5.3. Opportunities

3.5.3.1. Lucrative opportunities in emerging economies

Chapter: 4 CARDIAC SURGICAL DEVICES MARKET, BY PRODUCT TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. BEATING HEART SURGERY SYSTEMS

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast

4.3. CARDIOPULMONARY BYPASS EQUIPMENT

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast

4.4. CARDIAC ABLATION DEVICE

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast

4.5. PERFUSION DISPOSABLE

4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast

Chapter: 5 CARDIAC SURGICAL DEVICES MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. CONGENITAL HEART DEFECTS

5.2.1. Market size and forecast

5.3. CARDIAC ARRHYTHMIA

5.3.1. Market size and forecast

5.4. CORONARY HEART DISEASES

5.4.1. Market size and forecast

5.5. CONGESTIVE HEART FAILURE

5.5.1. Market size and forecast

5.6. OTHER APPLICATIONS

5.6.1. Market size and forecast

Chapter: 6 CARDIAC SURGICAL DEVICES MARKET, BY AGE-GROUP

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NEW-BORN POPULATION (0-30 DAYS)

6.2.1. Market size and forecast

6.3. INFANT POPULATION (31 DAYS-1 YEAR)

6.3.1. Market size and forecast

6.4. CHILDREN POPULATION (1-18 YEARS)

6.4.1. Market size and forecast

6.5. ADULT POPULATION (18+ YEARS)

6.5.1. Market size and forecast

Chapter: 7 CARDIAC SURGICAL DEVICES MARKET, BY GEOGRAPHY

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S. market size and forecast
7.2.5. Canada market size and forecast
7.2.6. Mexico market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. Germany market size and forecast
7.3.5. France market size and forecast
7.3.6. UK market size and forecast
7.3.7. Italy market size and forecast
7.3.8. Spain market size and forecast
7.3.9. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. China market size and forecast
7.4.5. Japan market size and forecast
7.4.6. India market size and forecast
7.4.7. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Latin America market size and forecast
7.5.5. Middle East market size and forecast
7.5.6. Africa market size and forecast

Chapter: 8 COMPANY PROFILES

8.1. ABBOTT LABORATORIES

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments

8.2. ANGIODYNAMICS, INC.

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance

8.3. BOSTON SCIENTIFIC CORPORATION

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments

8.4. COOK MEDICAL

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments

8.5. EDWARDS LIFE SCIENCE CORPORATION

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments

8.6. SORIN S.P.A.

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments

8.7. GETINGE GROUP

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments

8.8. MEDTRONIC INC.

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments

8.9. ATRION CORPORATION

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance

8.10. TERUMO MEDICAL CORPORATION

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL CARDIAC SURGICAL DEVICES MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 2. GLOBAL BEATING HEART SURGERY SYSTEMS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 3. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 4. GLOBAL CARDIAC ABLATION DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 5. GLOBAL PERFUSION DISPOSABLES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 6. GLOBAL CARDIAC SURGICAL DEVICES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 7. GLOBAL CARDIAC SURGICAL DEVICES MARKET FOR CONGENITAL HEART DEFECTS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 8. GLOBAL CARDIAC SURGICAL DEVICES MARKET FOR CARDIAC ARRHYTHMIA, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 9. GLOBAL CARDIAC SURGICAL DEVICES MARKET FOR CORONARY HEART DISEASES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 10. GLOBAL CARDIAC SURGICAL DEVICES MARKET FOR CONGESTIVE HEART FAILURE, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 11. GLOBAL CARDIAC SURGICAL DEVICES MARKET FOR OTHER APPLICATIONS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 12. GLOBAL CARDIAC SURGICAL DEVICES MARKET, BY AGE-GROUP, 2016-2023 ($MILLION)
TABLE 13. GLOBAL CARDIAC SURGICAL DEVICES MARKET FOR NEW-BORN POPULATION, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 14. GLOBAL CARDIAC SURGICAL DEVICES MARKET FOR INFANT POPULATION, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 15. GLOBAL CARDIAC SURGICAL DEVICES MARKET FOR CHILDREN POPULATION, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 16. GLOBAL CARDIAC SURGICAL DEVICES MARKET FOR ADULT POPULATION, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 17. CARDIAC SURGICAL DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 18. NORTH AMERICA CARDIAC SURGICAL DEVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 19. NORTH AMERICA CARDIAC SURGICAL DEVICES MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 20. NORTH AMERICA CARDIAC SURGICAL DEVICES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 21. NORTH AMERICA CARDIAC SURGICAL DEVICES MARKET, BY AGE-GROUP, 2016-2023 ($MILLION)
TABLE 22. EUROPEAN CARDIAC SURGICAL DEVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 23. EUROPEAN CARDIAC SURGICAL DEVICES MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 24. EUROPEAN CARDIAC SURGICAL DEVICES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 25. EUROPEAN CARDIAC SURGICAL DEVICES MARKET, BY AGE-GROUP, 2016-2023 ($MILLION)
TABLE 26. ASIA-PACIFIC CARDIAC SURGICAL DEVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 27. ASIA-PACIFIC CARDIAC SURGICAL DEVICES MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 28. ASIA-PACIFIC CARDIAC SURGICAL DEVICES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 29. ASIA-PACIFIC CARDIAC SURGICAL DEVICES MARKET, BY AGE-GROUP, 2016-2023 ($MILLION)
TABLE 30. LAMEA CARDIAC SURGICAL DEVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 31. LAMEA CARDIAC SURGICAL DEVICES MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 32. LAMEA CARDIAC SURGICAL DEVICES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 33. LAMEA CARDIAC SURGICAL DEVICES MARKET, BY AGE-GROUP, 2016-2023 ($MILLION)
TABLE 34. ABBOTT: COMPANY SNAPSHOT
TABLE 35. ABBOTT: OPERATING SEGMENTS
TABLE 36. ABBOTT: PRODUCT PORTFOLIO
TABLE 37. ANGIODYNAMICS: COMPANY SNAPSHOT
TABLE 38. ANGIODYNAMICS: OPERATING SEGMENTS
TABLE 39. ANGIODYNAMICS: PRODUCT PORTFOLIO
TABLE 40. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 41. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 42. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 43. COOK: COMPANY SNAPSHOT
TABLE 44. COOK: OPERATING SEGMENTS
TABLE 45. COOK: PRODUCT PORTFOLIO
TABLE 46. EDWARDS LIFE SCIENCE: COMPANY SNAPSHOT
TABLE 47. EDWARDS LIFESCIENCE: OPERATING SEGMENTS
TABLE 48. EDWARDS LIFE SCIENCE: PRODUCT PORTFOLIO
TABLE 49. SORIN: OPERATING SEGMENTS
TABLE 50. SORIN: PRODUCT PORTFOLIO
TABLE 51. GETINGE: COMPANY SNAPSHOT
TABLE 52. GETINGE: OPERATING SEGMENTS
TABLE 53. GETINGE (MAQUET): PRODUCT PORTFOLIO
TABLE 54. MEDTRONIC: COMPANY SNAPSHOT
TABLE 55. MEDTRONIC: OPERATING SEGMENTS
TABLE 56. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 57. ATRION: COMPANY SNAPSHOT
TABLE 58. ATRION: OPERATING SEGMENTS
TABLE 59. ATRION (QUEST MEDICAL): PRODUCT PORTFOLIO
TABLE 60. TERUMO: COMPANY SNAPSHOT
TABLE 61. TERUMO: OPERATING SEGMENTS
TABLE 62. TERUMO: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 1. GLOBAL CARDIAC SURGICAL DEVICES MARKET, 2016-2023
FIGURE 2. GEOGRAPHICAL SNAPSHOT OF GLOBAL CARDIAC SURGICAL DEVICES MARKET, 2016-2023
FIGURE 3. CARDIAC SURGICAL DEVICES: MARKET SEGMENTATION
FIGURE 4. TOP INVESTMENT POCKETS
FIGURE 5. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 6. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 7. MARKET SHARE ANALYSIS, 2016
FIGURE 8. U.S. CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 9. CANADA CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 10. MEXICO CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 11. GERMANY CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 12. FRANCE CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 13. UK CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 14. ITALY CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 15. SPAIN CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 16. REST OF EUROPE CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 17. CHINA CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 18. JAPAN CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 19. INDIA CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 20. REST OF ASIA-PACIFIC CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 21. LATIN AMERICA CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 22. MIDDLE EAST CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 23. AFRICA CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 24. ABBOTT: NET SALES, 2014-2016 ($MILLION)
FIGURE 25. ABBOTT: REVENUE BY SEGMENTS, 2016 (%)
FIGURE 26. ABBOTT: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 27. ANGIODYNAMICS: NET SALES, 2014-2016 ($MILLION)
FIGURE 28. ANGIODYNAMICS: REVENUE BY PRODUCT CATEGORY, 2016 (%)
FIGURE 29. ANGIODYNAMICS: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 30. BOSTON SCIENTIFIC: NET SALES, 2014-2016 ($MILLION)
FIGURE 31. BOSTON SCIENTIFIC: REVENUE BY SEGMENTS, 2016 (%)
FIGURE 32. BOSTON SCIENTIFIC: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 33. EDWARDS LIFE SCIENCE: NET SALES, 2014-2016 ($MILLION)
FIGURE 34. EDWARDS LIFE SCIENCE: REVENUE BY SEGMENTS, 2016 (%)
FIGURE 35. EDWARDS LIFE SCIENCE: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 36. SORIN: NET SALES, 2014-2016 ($MILLION)
FIGURE 37. SORIN: REVENUE BY SEGMENT, 2016 (%)
FIGURE 38. SORIN: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 39. GETINGE: NET SALES, 2014-2016 ($MILLION)
FIGURE 40. GETINGE: REVENUE BY SEGMENTS, 2016 (%)
FIGURE 41. GETINGE: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 42. MEDTRONIC: NET SALES, 2014-2016 ($MILLION)
FIGURE 43. MEDTRONIC: REVENUE BY SEGMENTS, 2016 (%)
FIGURE 44. MEDTRONIC: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 45. ATRION: NET SALES, 2014-2016 ($MILLION)
FIGURE 46. ATRION: REVENUE BY PRODUCT CATEGORY, 2016 (%)
FIGURE 47. ATRION: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 48. TERUMO: NET SALES, 2014-2016 ($MILLION)
FIGURE 49. TERUMO: REVENUE BY SEGMENTS, 2016 (%)
FIGURE 50. TERUMO: REVENUE BY GEOGRAPHY, 2016 (%)

 

Common cardiovascular conditions include rheumatic heart disease, hypertensive heart failure, ischemic heart disease, cardiovascular disease, inflammatory heart disease, and others. Cardiac surgery is the procedure used for the treatment for cardiac disorders. Different cardiac surgical devices are used for this procedure such as beating heart surgery systems, cardiopulmonary bypass equipment, cardiac ablation devices, and perfusion disposables. Perfusion disposable held the largest market value in 2016 and is expected to lead the market during the analysis period owing to high use of perfusion disposable as perfusion products are used to temporarily replace the functions of the heart and lungs during cardiac surgery procedures.

North America held the highest share owing to unhealthy lifestyles of the people, improper diet, and growth in elderly population, which results in the risk of heart disorders. In accordance to the estimates of the American Heart Association, nearly 98 million adults suffer from one or more types of cardiovascular disorders. Newer cardiovascular procedure is expected to play a significant role in enhancing the quality of life for patient groups with poor cardiac function. Asia-Pacific has the highest market potential due to rise in incidence of cancer, growth in per capita income in many countries such as India and China, government initiatives for the improvement of healthcare sector, and rise in focus of leading manufacturers on expanding their geographic presence in emerging Asia-Pacific countries to capture high growth opportunities in the market. Major companies involved in the cardiac surgical devices market are LivaNova PLC, Medtronic Inc., MAQUET GmbH & Co. KG, and Terumo Cardiovascular Systems Corporation.

 

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 
 

Purchase Full Report of
Cardiac Surgical Devices Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $4176
  • Online cloud Access only
  • Restected Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4640
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5540
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6654
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprice
    License/PDF

  • $9280
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  • Free quartery industry update
  • Free report update (Within 180 days)
  • Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts